Compare OGE & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGE | ICLR |
|---|---|---|
| Founded | 1902 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 8.2B |
| IPO Year | 2009 | 2001 |
| Metric | OGE | ICLR |
|---|---|---|
| Price | $47.57 | $105.91 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 13 |
| Target Price | $48.11 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 1.3M | 847.7K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.69% | N/A |
| EPS Growth | ★ 5.94 | N/A |
| EPS | ★ 2.32 | N/A |
| Revenue | ★ $3,260,100,000.00 | N/A |
| Revenue This Year | $3.74 | N/A |
| Revenue Next Year | $1.42 | N/A |
| P/E Ratio | $19.81 | ★ $12.91 |
| Revenue Growth | ★ 9.21 | N/A |
| 52 Week Low | $41.70 | $66.57 |
| 52 Week High | $50.13 | $211.00 |
| Indicator | OGE | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 47.67 | 42.87 |
| Support Level | $46.36 | $102.53 |
| Resistance Level | $49.16 | $114.75 |
| Average True Range (ATR) | 0.89 | 4.68 |
| MACD | -0.29 | 0.47 |
| Stochastic Oscillator | 40.98 | 17.57 |
OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution service for 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.